AlzChem Group AG EBIT

AlzChem Group AG (ALZCF) currently reports a EBIT of $84M as of September 2026. That compares with $91M in the prior-year period — down 7.3% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore AlzChem Group AG's EBIT history and peer comparisons.

AlzChem Group AG's EBIT decreased from $91M to $84M — a 7.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AlzChem Group AG's EBIT of $84M is lower than the its sector sector average of $2.6T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

AlzChem Group AG reported $84M in EBIT as of September 2026. That compares with $91M in the prior-year period — down 7.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $84M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for AlzChem Group AG, and consider following ALZCF for alerts when major investors trade the stock.